Parker J L
Postgrad Med J. 1979 Dec;55(654):908-10. doi: 10.1136/pgmj.55.650.908.
A first report of jaundice and hepatic necrosis probably due to potassium clorazepate is described. The histology is discussed and it is suggested that the drug should not be given in the presence of suspected hepatic dysfunction.
本文描述了首例可能由氯氮䓬钾引起的黄疸和肝坏死报告。文中对组织学进行了讨论,并建议在怀疑有肝功能障碍时不应使用该药物。